168 related articles for article (PubMed ID: 29284899)
1. Myometrium Invasion, Tumour Size and Lymphovascular Invasion as a Prognostic Factor in Dissemination of Pelvic Lymphatics at Endometrial Carcinoma.
Lucic N; Draganovic D; Sibincic S; Ecim-Zlojutro V; Milicevic S
Med Arch; 2017 Oct; 71(5):325-329. PubMed ID: 29284899
[TBL] [Abstract][Full Text] [Related]
2. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
[TBL] [Abstract][Full Text] [Related]
3. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
4. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
AlHilli MM; Podratz KC; Dowdy SC; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Mariani A
Gynecol Oncol; 2013 Oct; 131(1):103-8. PubMed ID: 23845691
[TBL] [Abstract][Full Text] [Related]
5. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.
Euscher E; Fox P; Bassett R; Al-Ghawi H; Ali-Fehmi R; Barbuto D; Djordjevic B; Frauenhoffer E; Kim I; Hong SR; Montiel D; Moschiano E; Roma A; Silva E; Malpica A
Am J Surg Pathol; 2013 Nov; 37(11):1728-36. PubMed ID: 24061515
[TBL] [Abstract][Full Text] [Related]
6. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma.
Hirahatake K; Hareyama H; Sakuragi N; Nishiya M; Makinoda S; Fujimoto S
J Surg Oncol; 1997 Jun; 65(2):82-7. PubMed ID: 9209518
[TBL] [Abstract][Full Text] [Related]
7. [Methods for preoperative and intraoperative evaluation of the tumour infiltration and lymph node metastases in endometrial cancer (summarized own and foreign experience)].
Ivanov S
Akush Ginekol (Sofiia); 2010; 49(4):21-4. PubMed ID: 20734637
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
Zhang C; Wang C; Feng W
Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
[TBL] [Abstract][Full Text] [Related]
9. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer.
Kumar S; Mariani A; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Podratz KC; Dowdy SC
Gynecol Oncol; 2013 Sep; 130(3):441-5. PubMed ID: 23747331
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
11. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
[No Abstract] [Full Text] [Related]
13. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.
Ayhan A; Şahin H; Sari ME; Yalçin I; Haberal A; Meydanli MM
Int J Gynecol Cancer; 2019 Mar; 29(3):505-512. PubMed ID: 30665899
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):435-40. PubMed ID: 21781585
[TBL] [Abstract][Full Text] [Related]
16. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
17. Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases.
Rechichi G; Galimberti S; Signorelli M; Franzesi CT; Perego P; Valsecchi MG; Sironi S
AJR Am J Roentgenol; 2011 Jul; 197(1):256-62. PubMed ID: 21701038
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
[TBL] [Abstract][Full Text] [Related]
19. The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis.
Dogan Altunpulluk M; Kir G; Topal CS; Cetiner H; Gocmen A
J Obstet Gynaecol; 2015 May; 35(4):397-402. PubMed ID: 25279582
[TBL] [Abstract][Full Text] [Related]
20. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.
Han G; Lim D; Leitao MM; Abu-Rustum NR; Soslow RA
Histopathology; 2014 Feb; 64(3):389-98. PubMed ID: 24215212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
